John L. Brottem
General Counsel · Alamar Biosciences, Inc.
IndividualSelling only
- 2024
- Sep 16, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John L. Brottem files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Illumina Innovation Fund II GP, L.L.C. - $4.00M in ALMR purchases and sales in the last 12 months
- Nicholas Naclerio - $4.00M in ALMR purchases and sales in the last 12 months
- Braden Michael Leonard - $870K in OM purchases and sales in the last 12 months
- Leslie Trigg - $114K in OM purchases and sales in the last 12 months
- Renee Gaeta - $107K in OM purchases and sales in the last 12 months
- Marc Nash - $45K in OM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John L. Brottem?
John L. Brottem is a corporate insider, tracked as General Counsel of Alamar Biosciences, Inc. (ALMR). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John L. Brottem submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has John L. Brottem been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($94K) across all tracked filings.
